RxDoctor Payments Data

David Ring, MD

Surgery · Aberdeen, SDNPI 1992017222

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,201 of the $4,780 with a category attached, or 67.0%. 27 manufacturers reported payments, led by Stryker at 36.7% of the total.

$4,780in general payments, 2019–2025

Across 67 payments — averaging $71.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Integra Lifesciences Corporation$791
  • Apollo Endosurgery US Inc$550
  • TEI Biosciences Inc$408
  • Organogenesis Inc.$197
  • Lemaitre Vascular, Inc.$155
  • plus $925 from 21 others

What the payments were for

  • Speaking & faculty fees$511%
  • Travel & lodging$3,20167%
  • Food & beverage$1,52832%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,780 in reported general payments places this provider in the 75th percentile of 87 surgery providers in South Dakota.

See all surgery providers in South Dakota

Medicare billing

Part B allowed, 2024
$318,759
Medicare patients
737
Services billed
1,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CholestyramineCholestyramine (With Sugar)19$1,042
Omeprazole112$898
Sucralfate24$713
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl30$538
Pantoprazole Sodium31$302
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl17$293
Cephalexin25$169
Metronidazole20$88
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$76
Neomycin Sulfate13$71
Lactulose13$13

Paid to pharmacies, not to this prescriber.

Other surgery in Aberdeen

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →